Royal Bank of Canada’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-500
| Closed | -$3K | – | 7156 |
|
2023
Q3 | $3K | Buy |
500
+436
| +681% | +$2.62K | ﹤0.01% | 6252 |
|
2023
Q2 | $0 | Buy |
+64
| New | – | ﹤0.01% | 7278 |
|
2022
Q2 | – | Sell |
-136
| Closed | -$4K | – | 7302 |
|
2022
Q1 | $4K | Sell |
136
-318
| -70% | -$9.35K | ﹤0.01% | 6863 |
|
2021
Q4 | $21K | Buy |
454
+170
| +60% | +$7.86K | ﹤0.01% | 6261 |
|
2021
Q3 | $23K | Buy |
284
+132
| +87% | +$10.7K | ﹤0.01% | 6120 |
|
2021
Q2 | $14K | Buy |
152
+52
| +52% | +$4.79K | ﹤0.01% | 6247 |
|
2021
Q1 | $17K | Sell |
100
-2
| -2% | -$340 | ﹤0.01% | 6036 |
|
2020
Q4 | $10K | Buy |
+102
| New | +$10K | ﹤0.01% | 5836 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 6407 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 6415 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 6250 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 6083 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 6227 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 6324 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 6072 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 6123 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 6186 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 5752 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 5754 |
|
2015
Q4 | – | Hold |
0
| – | – | – | 6050 |
|
2015
Q3 | – | Hold |
0
| – | – | – | 6149 |
|
2015
Q2 | – | Hold |
0
| – | – | – | 6174 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 5814 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 5671 |
|
2013
Q4 | – | Hold |
0
| – | – | – | 5485 |
|
2013
Q3 | – | Hold |
0
| – | – | – | 5614 |
|